Medtoruism

Turkey is among the top 10 healthcare destinations globally

Turkey is among the top 10 healthcare destinations globally- says Deloitte High quality treatment options offered by Turkish medical facilities at reasonable prices continue to attract hundreds of thousands of foreign healthcare More »

EMISusing

EMIS Web Helps Occupational Health Team Improve Care for 25,000 NHS Staff and Healthcare Students

One of the biggest NHS occupational health (OH) services in the UK is saving time and improving healthcare for over 25,000 staff and students thanks to EMIS Web. The Leeds Teaching Hospitals More »

nordic_walking

University of Leicester study finds walking 20 minutes per day can reduce health risks

University of Leicester study finds walking 20 minutes per day can reduce health risks An increase of just 2000 steps a day cuts cardiovascular disease risk by 8% in those with a More »

seeBaby

3D sonograms let blind expectant parents “see” their babies

3D sonograms let blind expectant parents “see” their babies Jorge Roberto Lopes dos Santos, an industrial designer with the Instituto Nacional de Tecnologia in Brazil, is giving doctors a new way to print sonograms More »

KONICA MINOLTA DIGITAL CAMERA

Hungarian drugmaker Richter bought a 70 percent stake in Mexican DNA Pharmaceuticals

Hungarian drugmaker Richter bought a 70 percent stake in Mexican  DNA Pharmaceuticals Hungarian drugmaker Richter said it bought a 70 percent stake in Mexican marketing partner DNA Pharmaceuticals for about $10 million, More »

stolen-macbook

Healthcare Data of 840,000 at Risk After Laptop Theft

Healthcare Data of 840,000 at Risk After Laptop Theft Thieves stole two laptops that may contain the unprotected personal data of around 840,000 customers from Horizon Blue Cross Blue Shield after breaking More »

tellspec_truffle

Smaller Than Your Phone, This Device Could Keep You Healthy

Smaller Than Your Phone, This Device Could Keep You Healthy Isabel Hoffmann‘s daughter fell sick after the family moved to the U.S. from Europe. The 14-year-old’s illness got progressively worse — hives, More »

sleeping-baby

Caesarean section delivery and the risk of allergic disorders in childhood.

 Caesarean section delivery and the risk of allergic disorders in childhood. Babies delivered by Caesarean section at higher risk of asthma and allergies Researchers found significant differences in the gut bacteria found More »

Happy-New-Year-2014-1-1

Top 5 MEDNEWSarticles of 2013

Here are the top 5 articles of the year 2013, with the stats. 5.  Doctor strikes continuing in Greece Public hospital doctors in Greece have embarked on a three-day walkout in a More »

dap_top40

The top 40 medical device manufacturers worldwide

The top 40 medical device manufacturers worldwide as ranked by total revenue as of October 17, 2013.   Rank    Company Name Stock Ticker              Total Revenue  More »

agreement

Siemens Enters into Master Agreement with Pfizer

Siemens Enters into Master Agreement with Pfizer Siemens Healthcare Diagnostics Inc. has entered into a master collaboration agreement with Pfizer Inc. to design, develop and commercialize diagnostic tests for therapeutic products across More »

Category Archives: Technology/science

EMIS Web Helps Occupational Health Team Improve Care for 25,000 NHS Staff and Healthcare Students

EMISusing

One of the biggest NHS occupational health (OH) services in the UK is saving time and improving healthcare for over 25,000 staff and students thanks to EMIS Web. The Leeds Teaching Hospitals NHS Trust is one of the first NHS OH departments in the UK to go entirely paperless with health care for its employees. Using EMIS’ transformational clinical system, the service is able to respond more quickly to health emergencies among staff and has significantly reduced admin time spent in preparing for OH clinics.

The SEQOHS-accredited department is one of the biggest in England, responsible for the occupational health of staff and students across several sites including two major hospitals – Leeds General Infirmary and St James’s University Hospital. Before introducing EMIS Web, the department was swamped in paperwork.

emis-logo-pm

Andrea Hildred, business manager for the Occupational Health Service, explained: “We have a multidisciplinary team of consultants, specialist nurse practitioners and advisors, psychiatrists, a psychologist and dedicated administration professionals. An individual member of staff may have interactions with any number of these team members from multiple sites. A paper-based records system was a massive headache as each interaction had to be recorded separately, collated and added to the employee’s OH file.

“We desperately wanted a system that would enable authorised team members to access and update an employee’s OH file safely, securely and in real-time – EMIS Web was the solution.”

“For example, in infection prevention and control, we may have a situation where 50 employees need to be followed up. In these scenarios we need to code, track and monitor employees and update OH records according to developments. With EMIS Web the process is quicker, safer and more accurate than paper records because the templates drive consistency and information gathered is in real-time.

“The system also enables us to react more efficiently in an emergency. For example, we support staff who are inadvertently exposed to blood. In these situations, enabling members across the team to view and update the affected individual’s file immediately is fantastic – the need for speed and accuracy is paramount.”

She added: “Preparing clinics is one of our biggest tasks. Getting each attendee’s file, ensuring clinicians have the right details and then updating individual employee OH files with notes and actions took a great deal of resource. With EMIS Web, time on this task is reduced because the data is there in a centralised hub – quickly accessible and updateable. The time saved by efficiencies like these mean the new system is effectively self-funding.

“Also, because the system is so adaptable, we’ve been able to really tailor it to our specific needs – creating bespoke templates and reports. This was a big plus for us.”

It’s not just the OH team that have been quick to see the benefits of the new system. “In some cases, it used to take several days to release reports for managers but now everything is done electronically on EMIS Web, the process is much quicker.”

The OH team is now looking at linking EMIS Web to an on-line health screening programme for assessing the health of student doctors and nurses.

http://www.emis-online.com/emis-web-helps-occupational-health-team-improve-care-for-25,000-nhs-staff-and-healthcare-students

Pin ItFollow Me on Pinterest

University of Leicester study finds walking 20 minutes per day can reduce health risks

nordic_walking

University of Leicester study finds walking 20 minutes per day can reduce health risks

An increase of just 2000 steps a day cuts cardiovascular disease risk by 8% in those with a high risk of type 2 diabetes

A large international study of people with impaired glucose tolerance (IGT; a precursor to diabetes) has found that every additional 2000 steps taken a day over one year—roughly equivalent to 20 min a day of moderately-paced walking—reduces the risk of cardiovascular events such as heart attack and stroke by 8%.

“People with IGT have a greatly increased risk of cardiovascular disease”, explains study leader Dr Thomas Yates from the University of Leicester in the UK in The Lancet. “While several studies have suggested that physical activity is beneficially linked to health in those with IGT, this is the first study to specifically quantify the extent to which change in walking behaviour can modify the risk of heart disease, stroke, and cardiovascular-related deaths.”*

IGT affects about 7.9% of the adult population (344 million people worldwide), and this number is projected to increase to 472 million (8.4%) by 2030.

Data on 9306 adults from 40 countries with IGT and cardiovascular disease or at least one cardiovascular risk factor were taken from the NAVIGATOR trial**. All participants received a lifestyle modification programme aimed at reducing body weight and dietary fat intake while increasing physical activity to 150min a week. Using a pedometer, researchers recorded usual walking activity (average number of steps taken per day) over a week both at the start of the study and again 12 months later.

Statistical modelling was used to test the relationship between the number of steps taken per day and the risk of subsequent cardiovascular disease after adjusting for a wide range of confounding factors such as body-mass index, smoking status, diet, clinical history, and medication use. 531 cardiovascular events were recorded during 45 211 person-years of follow-up.

Both levels of walking activity at the start of the study and change in walking activity over 12 months had a graded inverse association with subsequent risk of cardiovascular disease.

Specifically, for every 2000 steps per day difference in walking activity at the start of the study there was a 10% difference in the risk of cardiovascular disease in subsequent years. On top of this, the risk of cardiovascular disease was further modified by 8% for every 2000 steps per day that walking activity changed between the start of the study and 12 months later.

For example, if subject A took 4000 steps per day at the start of the study and did not change their activity levels over the next 12 months, and subject B took 6000 steps per day at the start of the study and increased their activity levels to 8000 steps per day over the next 12 months, by the end of the study (other things being equal) subject B would have an 18% lower risk of cardiovascular disease.

According to Yates, “Our results provide novel evidence that changing physical activity levels through simply increasing the number of steps taken can substantially reduce the risk of cardiovascular disease, such as heart attack and stroke. Importantly, these benefits are seen regardless of bodyweight status or the starting level of activity. These novel findings provide the strongest evidence yet for the importance of physical activity in high risk populations and will inform diabetes and cardiovascular disease prevention programmes worldwide.”*

Writing in a linked Comment, Giuseppe Pugliese and Stefano Balducci from La Sapienza University in Rome, Italy say, “The results from the NAVIGATOR add compelling and reassuring evidence on the benefits of physical activity on cardiovascular health, though there is the need for further observational and intervention studies with rigorous and objective assessment of physical activity and fitness.”

Ends

Notes to Editors:
*Quotes direct from author and cannot be found in text of Article.

**The NAVIGATOR trial tested whether treatments for diabetes and blood pressure could also prevent the onset of diabetes and cardiovascular events in patients aged 50 or more who had impaired glucose tolerance and cardiovascular risk factors or cardiovascular disease. Researchers analyzed data from 9306 adults from 806 centres in 40 countries who were randomised to the anti-hypertensive drug valsartan, the blood sugar lowering drug nateglinid, or placebo, and were tracked for an average of 6 years.

Dr Thomas Yates, Diabetes Research Unit, University of Leicester, Leicester, UK. E)   Dr Giuseppe Pugliese, La Sapienza University, Rome, Italy,  E) 

For full Article and Comment:

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)62061-9/abstract

Pin ItFollow Me on Pinterest

3D sonograms let blind expectant parents “see” their babies

seeBaby

3D sonograms let blind expectant parents “see” their babies

Jorge Roberto Lopes dos Santos, an industrial designer with the Instituto Nacional de Tecnologia in Brazil, is giving doctors a new way to print sonograms for their patients — as life-size replicas. The prenatal sonogram is a life-changing moment for many expectant parents, giving rise to the inherent value these images hold whether as printouts passed among family members or posts on social media. It’s one of the joyous benchmarks of pregnancy, but one that has been elusive to the visually impaired. Innovations in 3D printing, however, could change that.

Dos Santos’s company, Tecnologia Humana 3D, has been developing new ways to build three-dimensional computer models using data from sonograms and other imaging techniques after initially setting out to enhance prenatal diagnostic tools. The work took a new direction when dos Santos realized that printing these models would give visually impaired mothers-to-be a chance to meet their babies in utero. “We work mainly to help physicians when there is some eventual possibility of malformation,” dos Santos said. “We also work for parents who want to have the models of their fetuses in 3D.”

seebabyillustr

Tecnologia Humana designs the models with sophisticated programs that produce highly detailed simulations of a fetus’ anatomy that doctors can examine virtually. They can swoop through the lungs and explore the cavities of the heart in search of problems that may require intervention. Prior journeys have found Down syndrome and cleft lip, dos Santos said in a recent paper. Making a tangible model of a fetus requires one other step — plugging that data into a 3D printer, a device that can create objects by laying down successive layers of material.

Neva Fairchild, the resident expert on independent living at the American Foundation for the Blind, said the models would also benefit visually impaired family members looking to share in the experience of seeing their loved one’s unborn child for the first time.

A model would allow people with impaired vision to know the size of a fetus while giving them a new appreciation of those tiny toes and fingers. Fairchild, who is legally blind and can only discern shapes and shadows, speaks from experience. “Fifteen months ago, my first grandchild was born and they had numerous sonograms and I missed out on all of that,” she said.

 

seeBaby

Fairchild said it’s important, however, for the producers of these models to keep cost in mind. Many recent inventions designed to aid the visually impaired are too expensive for the people they’re meant to help, and most insurance policies are reluctant to cover these kinds of expenses, she said.

But dos Santos said his reliance on common imaging techniques, such as the MRI and the CT scan, keeps costs relatively low — about $200 for a full model of a fetus at 12 weeks, and about $300 for the face and arms of a fetus at 24 weeks.

http://io9.com/3d-sonograms-let-blind-expectant-parents-see-their-ba-472999403

Pin ItFollow Me on Pinterest

Hungarian drugmaker Richter bought a 70 percent stake in Mexican DNA Pharmaceuticals

KONICA MINOLTA DIGITAL CAMERA

Hungarian drugmaker Richter bought a 70 percent stake in Mexican  DNA Pharmaceuticals

Hungarian drugmaker Richter said it bought a 70 percent stake in Mexican marketing partner DNA Pharmaceuticals for about $10 million, as the company expands its presence in the fast-growing Latin American market.

As a result of the acquisition, Richter will hold an initial 70% stake in the Mexican company and will buy the remaining 30% in the next three years, Richter said in a release.

Financial terms weren’t disclosed.

Richter wants to use the Mexican firm for the registration of specialty products in the female healthcare therapeutic area, focusing primarily on Esmya, Richter’s drug to treat uterine fibroids, and the establishment of a related sales network. Following the purchase, the Mexican firm will be renamed Gedeon Richter Mexico S.A.P.I. de C.V.

The acquisition came on the heels of Richter announcing Monday that it had bought an initial majority stake in privately owned Brazilian drug distribution firm Next Pharma Representacao.

“Subsequent to the recently announced acquisition in Brazil, this cooperation with DNA is another strategic move aimed at the diversification of Richter’s geographic presence in Latin America, one of the regions with fastest growing pharmaceutical markets worldwide,” Richter chef executive Erik Bogsch said in the release.

Richter, a major drug maker in central and Eastern Europe, is already expanding in Western Europe and has a strong presence in Russia. Its product portfolio covers almost all major therapeutic areas, including gynecology, the central nervous system and cardiovascular system. In 2012, its consolidated sales totaled about $1.5 billion and its market capitalization was $3.1 billion.

Pin ItFollow Me on Pinterest

Healthcare Data of 840,000 at Risk After Laptop Theft

stolen-macbook

Healthcare Data of 840,000 at Risk After Laptop Theft

Thieves stole two laptops that may contain the unprotected personal data of around 840,000 customers from Horizon Blue Cross Blue Shield after breaking into the company’s Newark, N.J. headquarters on Nov. 1. One month later, the company began sending letters to its subscribers notifying them of the breach. Horizon issued a statement on Dec. 6 saying the stolen laptops were password protected, but the internal data was not encrypted. Due to the way the stolen laptops were configured, we are not certain that all of the member information contained on the laptops is accessible. We have no reason to believe that the laptops were stolen for the information they contained or that the information has been accessed or used in any way.

The two stolen laptops, which reportedly were MacBook Pros, were cable-locked to the employees’ workstations, but the thieves somehow broke the locks.

The company believes the laptops could have contained the personal information, including names, dates of birth, “limited clinical information” and social security numbers, according to The Star-Ledger. Company employers discovered the theft on Nov. 4 and immediately notified the police. There have been no arrests, and the thieves have not been identified. Thomas Vincz, a Horizon spokesperson, told SC Magazine that the company will provide free credit monitoring and identity theft protection to the affected subscribers. In a letter sent to a subscriber, who then shared it with Mashable, the company offers a one-year membership to Experian ProtectMyID Alert, an identity theft alert service, which normally costs $15.95 per month. There are multiple potential dangers for the victims if the thieves were to get their hands on the subscribers’ medical records, experts warn.

“Medical data is rife with clues which reveal other details about one’s personal life such as eating, fitness and lifestyle habits and perhaps some genetic resident diseases,” Carl Herberger, vice president of Security Solutions at Radware wrote in a blog post. “This provides a somewhat unique attribute for those who are interested in causing directed harm against a fellow person.” The thieves, Herberger explained, could impersonate the victims and access their medical insurance payments, sell their information or directly blackmail them — a technique that could particularly be effective against celebrities or people in a public positions, such as judges or high-ranking officials.

 

http://mashable.com/2013/12/19/horizon-blue-cross-blue-shield-laptop-theft/

Pin ItFollow Me on Pinterest

Smaller Than Your Phone, This Device Could Keep You Healthy

tellspec_truffle

Smaller Than Your Phone, This Device Could Keep You Healthy

Isabel Hoffmann‘s daughter fell sick after the family moved to the U.S. from Europe. The 14-year-old’s illness got progressively worse — hives, low blood pressure, tremors and light sensitivity — to the point that she had to drop out of school. To make matters worse, no doctor could determine what was causing the chronic illness.

Hoffmann, a serial entrepreneur who helped launch a preventive health clinic in 2001, took matters into her own hands. She brought her daughter to Dr. Neil Nathan, of Gordon Medical Associates in Santa Rosa, Calif., who’d written a book called, On Hope and Healing: For Those Who Have Fallen Through the Medical Cracks.

Dr. Nathan diagnosed Hoffmann’s daughter with mold toxicity, likely Aspergillus Penicillium, which causes severe allergic reactions and sensitivity to gluten, dioxins and other allergens. “He was dead right,” says Hoffmann. “We went back home and tested the house and learned we had high doses of Aspergillus and Penicillium mold in the bedroom.”

It had taken more than a year for Hoffmann to hear a proper diagnosis and learn the empowering information that could help her daughter get better. The family moved to a mold-free environment and the teenager started a new diet; symptoms vanished, she went back to school and her grades skyrocketed.

“That’s when I thought, “Oh my God, how many people go through life suffering so much? And almost giving up — with Chronic Fatigue Syndrome or Fibromyalgia — and resigning themselves to what they have, without a hope to be better?” says Hoffmann.

Hoffmann put her entrepreneurial skills to work, creating a handheld tool to help people like her daughter better understand their environments and the foods they’re consuming and how they affect the body.

This tool, she decided, “should be able to point at food and tell what food it is — if it has gluten, if it has dioxins — or point at the wall to see if the wall has mold and, if so, what kind. Point at the air we breathe and see if it has pollution, and so on,” says Hoffmann. Her friend Stephen Watson told her, “That sounds like Star Trek — I don’t think that’s a reality possible today.”

But it was, and today, Watson and Hoffmann are business partners on a biotech product calledTellSpec, a spectrometer that can parse the ingredients of whatever you point it at and beam this information to an accompanying smartphone app.

Have an allergy to soy? Are you lactose-intolerant? Do you break out in hives after consuming aspartame? Scanning foods with TellSpec will uncover the hidden ingredients and tip you off to any potential health issues it may cause. Do you have a physical reaction when you eat certain foods, but you’re not sure what’s causing it? Logging your symptoms after scanning food will help TellSpec determine what the culprit ingredient might be.

“If you report to us that every time you have some milk product, you have digestive problems, we’ll probably tell you, ‘It looks like you may be lactose intolerant, please speak with your nutritionist or doctor to confirm this.’ We’re not diagnosing, we are just guiding,” says Hoffmann.

tellspec_truffle

TellSpec was funded on Indiegogo, and it far exceeded its $100,000 goal (currently at $218,000, with five days remaining). While other spectrometers exist on the market already, Hoffmann says joining forces with Watson, a mathematician, meant TellSpec employ mathematical thinking, so the algorithm is smart and can better interpret what it’s scanning. “Our core IP is really the technology, the process. And this is the difference,” says Hoffmann. TellSpec beams a low-powered laser at the food in question, and low-energy photons are then emitted back to the TellSpec’s spectrometer, which sorts the photons by wavelength and determines what chemical compounds are within. The device is expected to hit the market in August 2014 at an initial price of $350-$400, and Hoffmann hopes demand will drive the price down to $50 in a few years.

We eat so badly, because we don’t know. We don’t have the time to really investigate,” says Hoffmann. ”So, when TellSpec says, ‘We found tartrazine (Yellow No. 5) in your food, it’s a yellow food dye that’s forbidden in China and a lot of Europe,’ you’ll wonder ‘What the heck is that yellow color doing in my corn chips?’ It’s there to make it look beautiful and more yellow. But come on, I think our health is more important than that.”

TellSpec is useful for people with allergies to things like soy or nuts — they can double-check that there’s no allergens in their food. It’s also a helpful tool for diabetics, since TellSpec can tell you calories per gram and outline how much fat, sodium and sugar are in a particular item you scan. Down the road, TellSpec will contain a camera so the device knows the volume of what you’re eating, too, and it can accurately indicate that you consumed 67 grams of sugar and 16 grams of fat in a given food. That data is powerful for people who need to be cognizant of what they’re putting in their bodies.

“What has been missing in big data is information about food — information about where this food exists in the world, which people are consuming it, how they’re consuming it, what effect it has, how that food relates to certain pathologies or certain symptoms,” says Hoffmann. “Imagine being able to detect, in countries with huge amounts of contaminants in water and food, that, in fact, the chemicals in the water are actually neurotoxins, and that’s why the area has a high incidence of neurological disorders.” Hoffmann has high hopes for TellSpec, its implications and its potential use cases for global health.

She hopes to build a massive database of food information that could nip potential epidemics — like a Salmonella outbreak or Mad Cow Disease — in the bud, since people would be logging their symptoms in real time. For example, the database could show a spike in gastrointestinal symptoms within a 5-mile radius, a tip-off that something’s amiss in the local food or water.

TellSpec won’t be equipped to scan for microscopic bacteria and viruses by August, but those advancements are on the agenda, which could help TellSpec become a global health tool. (Currently, spectrometer technology is calibrated and designed to check for one or two raw elements, such as salmonella, and the tool doesn’t always care what else is in the food. “It’s not [checking] for every single ingredient, just for the ones people think are of concern,” says Hoffmann. TellSpec aims to be a holistic tool.)

“Imagine having people worldwide scanning their food — all those scans are going to be in our server in the cloud, and they’re going to help other people, because our algorithm will know if we’ve seen this type of mixture already,” says Hoffmann. “We’re looking to build a footprint of food data that then can be correlated with other information — such as the symptoms that a person has after eating certain foods — to improve diagnosis, prognosis and treatments in individual lives.”

Hoffmann says building a greener world with healthier people is the real mission of TellSpec, and data is integral to that mission. “We really have to stop this massive genocide, these chemicals being put in our food and our environment,” says Hoffmann. “We’re killing ourselves, and we’re allowing this to happen.” By providing information about what’s in our environment and how we react to it, TellSpec could help individuals stay healthy and medical professionals provide better health care. “We continue to grow the population, but we don’t focus on the health aspects of raising that population; every single human being born today has a toxic burden equal to or higher than their mother,” she says.

“We have to stop the world from killing itself,” says Hoffmann, who’s banking on the knowledge gleaned from TellSpec’s data to keep us alive and well.

Homepage image: TellSpec

source: http://mashable.com/2013/11/26/tellspec/?utm_cid=mash-com-fb-main-link

Pin ItFollow Me on Pinterest

Caesarean section delivery and the risk of allergic disorders in childhood.

sleeping-baby

 Caesarean section delivery and the risk of allergic disorders in childhood.

Babies delivered by Caesarean section at higher risk of asthma and allergies

  • Researchers found significant differences in the gut bacteria found in infants born surgically and naturally
  • Exclusively bottle-fed babies also had significant differences in their gut bacteria
  • Previous research found children born surgically are at double the risk of obesity in childhood

Babies delivered by Caesarean miss out on protective bugs that could help prevent a host of disorders in childhood and later life, warn researchers. They found significant differences in the gut bacteria found in infants born surgically and naturally. Babies fed formula milk, rather than being breastfed, also lacked bacteria that may be protective, according to a new study in the Canadian Medical Association Journal.

Researchers said the findings would increase concern about potential lifelong effects for the baby from the soaring rate of Caesareans. Although emergency Caesarean births can be life-saving, planned surgery is recognised as riskier for mothers because they are more likely to develop complications and spend twice as long in hospital as women having a natural delivery. The latest study adds to worries about the hazards for infants after previous research suggested children born surgically are at double the risk of obesity in childhood, with a higher risk of developing type 1 diabetes and asthma. Although the exact reasons are unknown, surgical babies may be missing out on physiological changes that happen during labour including exposure to bugs which are necessary for the immune system to mature. The rate of surgical deliveries in England is almost 25 per cent, adding up to more than 190,000 a year. In some parts of London one in three hospital deliveries is by Caesarean.

The study looked at data on 24 healthy infants, as part of the larger Canadian Healthy Infant Longitudinal Development study, who were representative of Canadian newborns with 25 per cent born by Caesarean and 42 per cent breastfed exclusively at 4 months of age. The researchers used new DNA sequencing technology to investigate the gut bacterial composition of the babies, a technique that allows detection of virtually all the bugs present. Previous studies of this type have been conducted using laboratory cultures, which are limited as about 80 per cent of intestinal microbes cannot be grown in culture. The researchers found infants born surgically were lacking a specific group of bacteria found in infants delivered naturally, even if they were breastfed. Infants strictly formula-fed, compared with babies that were exclusively or partially breastfed, also had significant differences in their gut bacteria. Co-author Dr Anita Kozyrskyj, of the University of Alberta, said: ‘Our findings are particularly timely given the recent affirmation of the gut microbiota as a ‘super organ’ with diverse roles in health and disease, and the increasing concern over rising Caesarean delivery and insufficient exclusive breastfeeding.’  The potential long-term consequences of decisions regarding mode of delivery and infant diet are ‘not to be underestimated’, said the study report.

‘Infants born by Caesarean delivery are at increased risk of asthma, obesity and type 1 diabetes, whereas breastfeeding is variably protective against these and other disorders’ it said. Researcher Meghan Azad, of the University of Alberta, said: ‘We want parents (and physicians) to realize that their decisions regarding C-section and breastfeeding can impact their infant’s gut microbiome, and this can have potentially lifelong effects on the child’s health.’  Experts believe gut bacteria play a role in stimulating the immune system.

Because infants born surgically are not exposed to beneficial bacteria in the birth canal, they might take longer to accumulate good bugs, which delays exposure to microbes that kick start the immune system. Dr Rob Knight, a scientist at the University of Colorado, Boulder, Colorado, United States, in a related commentary, said: ‘Children born by Caesarean delivery or fed with formula may be at increased risk of a variety of conditions later in life; both processes alter the gut microbiota in healthy infants, which could be the mechanism for the increased risk.’

Read more: http://www.dailymail.co.uk/health/article-2277046/Babies-delivered-Caesarean-section-higher-risk-asthma-allergies.html#ixzz2or899JGg

Other interesting point of view is stated in this publication:

 Caesarean section delivery and the risk of allergic disorders in childhood.

The composition of the intestinal flora in young children, if unfavourable, may increase the susceptibility to allergic disorders. Beneficial intestinal microbes originate from the maternal vaginal tract and thus are more likely to be transferred during vaginal births than during Caesarean sections (C-sections).

To determine whether children born by C-section have a different risk of allergic disorders compared with those delivered vaginally. We also tested the hypothesis that the risk of allergic disorders is highest for children born after ‘repeat C-sections’.

Get more info: http://www.ncbi.nlm.nih.gov/pubmed/16297144

Pin ItFollow Me on Pinterest

Top 5 MEDNEWSarticles of 2013

Happy-New-Year-2014-1-1

Here are the top 5 articles of the year 2013, with the stats.

5.  Doctor strikes continuing in Greece

F36AE798-3DF8-4AD3-A901-747B1BE630EF_mw1024_n_s

Public hospital doctors in Greece have embarked on a three-day walkout in a show of protest against greater layoffs demanded by foreign lenders in the debt-stricken country.On Tuesday, Greek doctors and nurses have joined the latest wave of strikes by thousands of teachers, lawyers and civil servants who are protesting at the government’s plan to implement more lay-offs and forced redeployments. Doctors are protesting against the government’s plan to merge public hospitals, with the aim of reforming their professions.  The two-day civil service walkout is expected to affect public services across the country, including shutdowns of schools, hospitals and selected transport systems. https://medlines.org/doctor-strikes-continueing-greece/

 

 

4.Hospital or Hotel? Luxury Hospitals Entice Patients

All across the country, hospital visits are starting to feel a little bit more like a trip to a luxury resort. From room service to spa services to a room with a view, healthcare facilities are offering high-end amenities to entice new patients–and their insurers’ money.

The Ronald Reagan UCLA Medical Center opened its doors in 2008 and the luxe hospital’s “Better Way to Get Better” ad campaign featured private rooms, room service meals, massage therapists and views of Los Angeles. The campaign proved effective. According to the Hospital Consumer Assessment of Healthcare Providers and Systems, the proportion of patients who said they would recommend UCLA rose from 71% to 85% after the new and improved hospital opened. https://medlines.org/hospital-hotel-luxury-hospitals-entice-patients/

 

3. Hospitals warned over weekend care

NHS sign

Sir Bruce Keogh, NHS England’s medical director, said he was setting out “pretty radical changes” which were backed up with some “pretty hard levers” to make sure hospitals complied. He told t he Sunday Times that hospital trusts will be contractually bound to run a full service seven days a week – with breaches costing them up to 2.5% of their annual income of up to £500 million. Sir Bruce indicated the changes, which could cost around £1 billion to implement, would result in hospitals making more efficient use of equipment and expertise. https://medlines.org/hospitals-warned-weekend-care/

 

 

2. Lose up to 7 kgs with a new german diet

Diet

The diet is made up of German specialists, according to which women and men can lose up to 7 kg in 2 weeks This diet was developed by German experts in nutrition and is very popular in Germany. Therefore we called the German diet. Designed specifically for the German plump ladies seeking to lose weight. As claimed by its creators and those who have been applying the effect is very good – in 2 weeks you can lose up to 7 kg. https://medlines.org/lose-7-kgs-new-german-diet/

 

 

 

1. They pay less for hungarian doctors than other workers- Medical salaries Europe

Euro_coins_and_banknotesWe have wrote and posted many articles about, doctors leaving because of the financial crunch they are feeling. Many countries pay well, many pay ridicuolusly low wages. Let’s take a look at the current latest stats on Medical salaries. At least we can see the 2011 salaries, which could be outdated in some countries, but can give you a quick hint, on understanding the migration of medical doctors and other medical workers. It has been prepared by the  FEDERATION EUROPEENNE DES MEDECINS SALARIES EUROPEAN FEDERATION OF SALARIED DOCTORS, and it is reachable at their website.  https://medlines.org/they-pay-less-for-a-hungarian-doctors-than-other-workers-medical-salaries-europe/

We would like to thank you for everybody sharing our articles, posting our stories and commenting it either on our website or on  social media platforms. Wish you all the best for 2014.

MEDLINES

Pin ItFollow Me on Pinterest

The top 40 medical device manufacturers worldwide

dap_top40

The top 40 medical device manufacturers worldwide as ranked by total revenue as of October 17, 2013.

 

Rank 

 

Company Name Stock Ticker              Total Revenue  Market Capitalization
1 Johnson & Johnson NYSE: JNJ $28.6 billion  

$258.2 billion

2 Siemens AG DB:SIE $18.7 billion  

$104.6 billion

3 General Electric Co. NYSE:GE $18.3 billion  

$260.2 billion

4  

 

Medtronic Inc.

 

NYSE:MDT $16.7 billion  

$56.4 billion

5 Baxter International Inc. NYSE:BAX $14.3 billion  

$35.8 billion

6 Fresenius Medical Care AG & Co. KGAA  DB:FME $14.2 billion  

$20.5 billion

7 Koninklijke Philips Electronics NV ENXTAM:PHIA $13.5 billion  

$30.6 billion

8 Covidien plc  NYSE:COV $12.1 billion  

$29.1 billion

9 Novartis AG1 SWX:NOVN $10.4 billion  

$183.5 billion

10 Cardinal Health Inc. NYSE:CAH $10.1 billion  

$19.0 billion

11 Stryker Corp. NYSE:SYK $8.8 billion  

$27.8 billion

12 Becton, Dickinson and Co. NYSE:BDX $7.9 billion  

$20.4 billion

13 Boston Scientific Corp. NYSE:BSX $7.1 billion  

$16.5 billion

14 Essilor International SA ENXTPA:EI $6.5 billion $22.9 billion
15 Allergan Inc.  NYSE:AGN $6.1 billion  

$26.9 billion

16 St. Jude Medical Inc. NYSE:STJ $5.5 billion  

$16.3 billion

17 3M Co. NYSE:MMM $5.3 billion  

$84.0 billion

18 Zimmer Holdings Inc. NYSE:ZMH $4.5 billion  

$15.1 billion

19 Terumo Corp. TSE:4543 $4.2 billion  

$9.4 billion

20 Smith & Nephew plc  LSE: SN $4.2 billion  

$11.4 billion

21 Olympus Corp.  TSE:7733 $4.0 billion  

$10.7 billion

22 Getinge AB  OM:GETI B $3.9 billion  

$7.6 billion

23 Toshiba Corp. TSE:6502 $3.8 billion  

$18.6 billion

24 Bayer AG2 DB:BAYN $3.6 billion  

$102.5 billion

25 CareFusion Corp. NYSE:CFN $3.6 billion $8.4 billion
26 Abbott Laboratories3 NYSE:ABT $3.0 billion  

$58.0 billion

27 CR Bard Inc.  NYSE:BCR $3.0 billion  

$9.9 billion

28 DENTSPLY International Inc. NasdaqGS:XRAY $2.9 billion  

$6.5 billion

29 Varian Medical Systems Inc.  NYSE:VAR $2.9 billion  

$8.5 billion

30 Hologic Inc. NasdaqGS:HOLX $2.4 billion  

$6.0 billion

31 Intuitive Surgical Inc.  NasdaqGS:ISRG $2.3 billion  

$14.3 billion

32 Paul Hartmann AG  DB:PHH2 $2.3 billion  

$1.3 billion

33 Dragerwerk AG & Co. KGa4 DB:DRW3 $2.2 billion  

$1.8 billion

34 Hoya Corp.5 TSE:7741 $2.1 billion  

$10.3 billion

35 Danaher Corp.6 NYSE:DHR $2.1 billion  

$50.2 billion

36 BioMérieux SA  ENXTPA:BIM $2.0 billion  

$3.8 billion

37 Coloplast A/S CPSE:COLO B $2.0 billion $12.9 billion
38 Edwards Lifesciences  NYSE:EW $2.0 billion  

$8.7 billion

39 MIRACA Holdings Inc.  TSE:4544 $2.0 billion  

$2.6 billion

40 Sonova Holdings SWX:SOON $1.9 billion  

$8.6 billion

 

Source: Capital IQ and company data.

1The Alcon division is only included in this report.
2Medical Care comprises the businesses with blood glucose meters, contrast-enhanced
diagnostic imaging equipment, and mechanical systems for treating constricted or blocked blood
vessels.
3The medical devices segment is only included in this report.
4The medical devices segment is only included in this report.
5Restructured Life Care division. In the Life Care business, the Group produces and sells health care related products that are used in the health care and medical sectors and medical related products, including medical equipment and
medical materials that are used in medical treatments.
6Separated Medical Technologies into Dental and Life Sciences & Diagnostics sgements. The Dental division is only included in this report.

source: http://www.mddionline.com/article/top-40-medical-device-companies

Pin ItFollow Me on Pinterest

Siemens Enters into Master Agreement with Pfizer

agreement

Siemens Enters into Master Agreement with Pfizer

Siemens Healthcare Diagnostics Inc. has entered into a master collaboration agreement with Pfizer Inc. to design, develop and commercialize diagnostic tests for therapeutic products across Pfizer’s pipeline. Under the agreement, Siemens will be one of Pfizer’s collaboration partners to develop and provide in vitro diagnostic tests for use in clinical studies and, potentially, eventual global commercialization with Pfizer products.

The partnership will leverage Siemens’ worldwide leadership in providing clinical diagnostic solutions for hospital and reference laboratories, specialty laboratories and point-of-care settings (including clinics and physician offices) to help enable diagnostics development.

“Companion diagnostics are an important enabler of targeted therapies for patients,” said John Hubbard, Senior Vice President and Worldwide Head of Development Operations at Pfizer. “This agreement with Siemens Healthcare Diagnostics is another example of Pfizer’s commitment to develop new precision medicines to address unmet clinical needs.”

Companion diagnostic tests are clinical tests linked to a specific drug or therapy intended to assist physicians in making more informed and personalized treatment decisions for their patients. When used in the drug development process, companion diagnostics may help pharmaceutical companies improve patient selection and treatment monitoring, determine the preferred therapy dosing for patients, and establish a protocol to help maximize the treatment benefit for patients.

“Our relationship with Pfizer marks a major milestone in Siemens’ personalized medicine strategy,” commented Dr. Trevor Hawkins, Senior Vice President, Strategy & Innovations, Diagnostics Division, Siemens Healthcare. “We look forward to collaborating with Pfizer to realize the goal of advancing innovative solutions that change the way patient care is delivered and, together, shape the future of diagnostic medicine.”

The Siemens Clinical Laboratory (SCL), a “high-complexity”, cutting-edge testing laboratory focused on advancing personalized medicine, will develop the companion diagnostic tests under the master agreement.

About Siemens Healthcare
The Siemens Healthcare Sector is one of the world’s largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 52,000 employees worldwide and operates around the world. In fiscal year 2013 (to September 30), the Sector posted revenue of 13.6 billion euros and profit of 2.0 billion euros.

Pin ItFollow Me on Pinterest